He also counsels clients on matters related to the Fair Labor Standards
Act and the Family and Medical Leave Act. . Dynavax s pipeline
includes: a ragweed allergy immunotherapeutic, currently in a large-scale
Phase 2/3 clinical trial, and in a supportive clinical trial in ragweed
allergic children; a hepatitis B vaccine that is currently in a Phase 2/3
clinical trial; a cancer therapy currently in a Phase 2 clinical trial; and an
asthma immunotherapeutic that has shown preliminary safety and pharmacology in
a Phase 2a clinical trial.